We previously demonstrated that resident alveolar macrotor-␣ (TNF-␣), which indirectly recruits polymorphonuphages from naive mice do not synthesize interleukin (IL)-10, clear neutrophils (PMN) into the inflammatory site (2, 3).
tion.
by bone marrow-derived macrophages (15) . SP-A, a member of the collectin family of C-type lectins (which includes Lipopolysaccharides (LPS), which are biologically active serum mannose-binding lectin, SP-D, and conglutinin [16] ), components of the outer membrane of gram-negative bacteis highly conserved across species, attesting to its imporria, are important inducers of septic shock and acute respiratance in pulmonary function. Previous studies have shown tory distress syndrome (ARDS), a lung injury state with a that SP-A plays an important role in innate immunity by high mortality rate (1). LPS activates monocytes/macroaffecting the ability of alveolar macrophages to perform phages and induces the production of a number of molehost defense as demonstrated in vitro for functions such as cules, including cytokines such as the tumor necrosis facphagocytosis (17) , generation of reactive oxygen species (18), and production of TNF-␣ (19). Based on the demonstration that the LPS-induced production of IL-10 by newly (Received in original form April 18, 2002 and in revised form August 20,  recruited mononuclear phagocytes decreases within several 2002) days in vitro (15) , we hypothesized that endogenous SP-A could repress IL-10 synthesis.
(15.6-2,000 pg/ml) or samples were added to coated plates for 18 h
Materials and Methods
at 4ЊC. This was followed by epitope immobilization and epitope
Reagents
release. Thus, after washing the plates (phosphate buffer 10 mM, LPS (Escherichia coli O55:B5) was from Sigma-Aldrich (St. Louis, pH 7.4, 0.1% Tween 20), a 0.25% glutaraldehyde solution (100 MO). Human SP-A was isolated from the lung washings of patients l) was added into each well, and the reaction was allowed to with alveolar proteinosis by a modification of the method of Suproceed for 5 min at 20ЊC while stirring. Wells were then washed, wabe and colleagues (20) , which includes a serial sedimentation and 100 l/well of a 10 mg/ml borane-trimethylamine complex of the surfactant pellet in the presence of 1 mM Ca 2ϩ , elution with solution containing 1 N HCl was added for an additional 5 min EDTA and adsorption to mannose-sepharose. The level of LPS while shaking. Finally, after a washing step, the binding of the associated with the SP-A was 140 pg LPS/g SP-A. Diff-Quik labeled antibody was performed by adding 100 l/well of the JESproducts were from Dade Behring (Paris, France) and the tetra-2A5-AchE conjugate at the concentration of 10 Ellman U/ml for methylbenzidine substrate was from Kirkegaard-Perry-Labora-18 h at 4ЊC. For measurements of the solid-phase bound enzyme tories (Gaithersburg, MD). Rat anti-murine TNF-␣ monoclonal activity, plates were extensively washed and solid-phase bound Ab (mAb), MP6-XT3 and MP6-XT22, and the anti-murine IL-10 AchE activity was determined colorimetrically by adding 200 l mAb, JES-2A5, were kind gifts of M. A. Nahori (Institut Pasteur, of Ellman's medium. Absorbance was read at 405 nm. The lower Paris, France), and these same mAb conjugated with acethylchollimit of detection of this assay is ϳ 10 pg IL-10/ml sample. inesterase (AchE) were prepared by C. Creminon (Commissariat à l'Energie Atomique, Saclay, France). R-phycoerythrin(PE)-conjugated rat anti-mouse Ly-6G (Gr-1) and Ly-6C mAb (RB6-8C5)
Measurement of Immunoreactive TNF-␣ Content of
was from PharMingen (San Diego, CA). The anti-granulocyte mAb RB6-8C5 was prepared as previously described (21) . Recom-
Supernatants by Enzyme Immunometric Assay
binant murine IL-10 and TNF-␣ was obtained from Immugenex Levels of TNF-␣ in the BALF and cell supernatants were also (Los Angeles, CA).
determined by an enzyme immunometric assay as previously described (14). Immunometric assays were performed in 96-well microtiter plates (MaxiSorp; Nunc), coated with 10 g/ml anti-TNF-␣ mAb, MP6-XT3. The one-step procedure used for immunometric
Administration of LPS, SP-A, or RB6-8C5 to Mice
assays involved the simultaneous addition of 100 l of TNF-␣ Seven-week-old male C57Bl/6 mice weighing 25-30 g, provided standards (7.8-1,000 pg/ml) or samples, and 100 l of the by the Centre d'Elevage R. Janvier (Le Genest St. Isle, France), anti-TNF-␣ mAb, MP6-XT22-AchE conjugate, at the concentrawere lightly anesthetized by ether inhalation and intranasally inoction of 10 Ellman U/ml. The following steps were performed exulated with 330 g/kg of sonicated LPS or 3 g of SP-A dissolved actly as described for IL-10. The lower limit of detection of this in 50 l of saline. In some experiments, mice were treated intraveassay is ϳ 15 pg TNF-␣/ml sample. nously with the mAb RB6-8C5 at a concentration of 10 g/mice 24 h before LPS challenge, and at a concentration of 5 g/mice 24 h before BALF collection. Mice were cared for in accordance with Pasteur Institut guidelines in compliance with the European
Measurement of Immunoreactive SP-A Content
animal welfare regulations.
of Supernatants
SP-A level in the BALF was determined by enzyme-linked immunosorbent assay (ELISA) as previously described (24) . Briefly,
Collection of BALF
ELISA was performed in 96-well microtiter plates, coated overnight at room temperature with 10 g/ml of anti-SP-A polyclonal At different time intervals, animals were killed by an intraperitoAb diluted in 0.1 M NaHCO 3 . To block nonspecific binding, plates neal administration of a lethal dose of sodium pentobarbital (Sawere incubated 30 min at room temperature with a solution of 3% nofi, Libourne, France). The trachea of each mouse was cannudry milk, 1% triton in phosphate-buffered saline. For immunologic lated, and bronchoalveolar lavage was performed with a syringe capture, 100 l of native rat SP-A standards (156.25-20,000 pg/ml) by multiple cycles of instillation and aspiration with unitary 0.5 ml or samples serial dilutions were loaded. Following an incubation at saline to provide either 1 ml of BALF for cytokine determination 37ЊC for 1.5 h, plates were washed three times, and 100 l of a 20 or 4 ml of BALF for cell isolation. There were no significant l/ml solution of anti-SP-A Ab coupled to horseradish peroxidase differences in the total volume of saline infused into the lungs or was added to each well. Then plates were incubated for an addiin the volume recovered after the lavage procedure among any tional 1.5 h at 37ЊC. After the last wash, 100 l of tetramethylbenziexperimental groups. Collected cells were counted (Coulter Elecdine substrate were added to each well. Plates were then placed tronics Limited, Luton, UK) and cell differential counts were deterin the dark for 15 min, and the reaction was stopped by adding mined after cytospin centrifugation and staining with Diff-Quik products. Cytokine concentrations were measured in the cell-free 100 l of sulfuric-acid-2N. Plates were read at 450 nm with an BALF obtained after centrifugation (300 ϫ g for 15 min).
automatic microplate reader.
Measurement of Immunoreactive IL-10 Content of Isolation of Mononuclear Cells from BALF Supernatants by Immunoenzyme Assay
Cells from BALF were counted and incubated 30 min at 4ЊC at the appropriate ratios with PE-conjugated RB6-8C5 mAb that Concentrations of IL-10 were determined by a solid phase immuselectively binds PMN and eosinophils. Cells were washed twice noenzyme assay (SPIE-IA) (22, 23) as previously described (14).
and incubated with MACS anti-PE microbeads (Miltenyi Biotec, Briefly, the SPIE-IA is an immunometric assay using the same Bergish Gladbach, Germany) for 15 min at 4ЊC. After washing, anti-murine IL-10 (JES-2A5) mAb for both capture and revelation cells were resuspended in 5 ml of phosphate-buffered saline/0.5% steps. Assays were performed in 96-well microtiter plates (Maxifetal calf serum, and mononuclear cells were isolated by passing the Sorp; Nunc, Roskilde, Denmark), coated with 10 g/ml purified JES-2A5. For the immunologic capture, 100 l of IL-10 standards Ab-coated cell suspensions through a column on an AutoMACS magnetic cell separator. Mononuclear cells were counted and used for mRNA extraction.
mRNA Extraction and RT-PCR for TNF-␣, IL-10, and ␤-Actin
Total RNA were isolated from purified mononuclear cells according to the method described by Chomczynski and Sacchi (25) . cDNA were produced by incubating 5 g of total RNA, 0. 
Statistical Analysis
Results were expressed as means Ϯ SEM for the indicated number of independently performed experiments. Comparisons between values were analyzed by the Student's t test for unpaired data and P values of less than 0.05 were considered significant.
Results

Time Course of LPS-Induced Cell Recruitment, and IL-10 and TNF-␣ Productions in Inflamed Lungs of Mice
We have previously shown that during the lung inflammatory process induced by LPS, newly recruited mononuclear phagocytes are transiently competent for IL-10 production when exposed to LPS in vitro (15) . We wanted to test this competence under in vivo conditions. A first administration of LPS was performed to induce the recruitment of inflam- . SP-A concentration in the BALF after intranasal administration of LPS. BALF were collected each day after a single intranasal administration of LPS (330 g/kg) and SP-A concentrations were determined by ELISA in cell-free supernatants of the BALF as described in Materials and Methods. Results are means Ϯ SEM (n ϭ 6). * P Ͻ 0.04 and **P Ͻ 0.008. 
IL-10 and TNF-␣ mRNA Expression by Mononuclear Cells after LPS-Induced Lung Inflammation
SP-A Concentration in the BALF after Intranasal Administration of LPS
At Day 4, there was no more IL-10 detectable in BALF, challenge (15 min, 25.2 Ϯ 14.8 pg/ml; 1 h, 66.5 Ϯ 23.8 pg/ml; although the influx of monocytes which produce IL-10 was 3 h, 174.7 Ϯ 37.5 pg/ml; 6 h, 207.9 Ϯ 37.9 pg/ml; and 24 h, maximal at this time. Our previous report showed that 184.3 Ϯ 24.1 pg/ml, mean Ϯ SEM, n ϭ 5).
SP-A, an alveolar protein with known immunomodulatory Contrasting to time course of IL-10 production, the activities, dramatically inhibits LPS-induced IL-10 forma-BALF TNF-␣ concentration displayed no significant variation by bone marrow-derived macrophages (15) . These data tion until Day 5, after which it declined progressively. It is suggested a possible role for SP-A in the in vivo regulation important to note that LPS administration to naive mice of IL-10 production in our inflammatory model. To verify did not induce IL-10 production (see Day 0), indicating that this hypothesis, we first measured the SP-A concentration resident cells are incompetent for the synthesis of IL-10.
in BALF as a function of time after one administration of LPS, to evaluate the quantity of SP-A at the time of the Furthermore, PMN did not account for the IL-10 production. Indeed, when mice were pretreated with a mAb (RB6-second LPS administration. As shown in Figure 4 , SP-A concentration decreased slowly until Day 3 (P Ͻ 0.04, Day 8C5) that selectively binds and depletes mouse PMN (21), we observed no significant difference for IL-10 production 0 versus Day 3, n ϭ 6) and then increased significantly at Day 4 through Day 7 (P Ͻ 0.008, Day 3 versus Day 4, between treated (167 Ϯ 45 pg/ml) and control mice (190 Ϯ 26 pg/ml) at Day 3 (mean Ϯ SEM, n ϭ 3, P Ͼ 0.05). These n ϭ 6). These findings clearly show that SP-A and IL-10 concentrations vary conversely, suggesting a relationship results are consistent with our previous report (15) , and indicate that newly recruited monocytes are responsible for between the repression of IL-10 production by monocytes and the increase of SP-A level in the airspaces. the IL-10 production observed in inflamed lungs.
to secrete IL-10 in a candidiasis model. To rule out PMN as a potential source of IL-10 in our model, mice were depleted from PMN before LPS treatment (21) . Under these conditions, IL-10 was still detectable with similar concentrations and kinetics. In addition, cells collected from the airways at Day 3 expressed IL-10 mRNA even after the removal of PMN by AutoMACS magnetic cell separator (see Materials and Methods). Concerning T cells, it is well known that they produce IL-10 (29). Nonetheless, in the present study, T cells were not detected in the airways vivo inhibition of IL-10 synthesis during lung inflammation. there was a significant decrease of IL-10 production in mice First, we observed an inverse relationship between the rethat received SP-A, whereas TNF-␣ production was the pression of IL-10 production by monocytes and the increase same ( Figure 5 ). Total cells and PMN counts were similar of SP-A level in the BALF between Days 3 and 4. McIntosh between the two mouse groups (data not shown). Collecand colleagues (30) also showed an increase of SP-A levels tively, these data indicate that exogenous SP-A specifically in lavage fluid of LPS-treated rats. They concluded that this represses IL-10 production.
upregulation might be a protective response for the lung. Several mechanisms could potentially account for the SP-A Discussion level augmentation. One possibility is that the metabolism of SP-A is altered, either through a decrease of its uptake Innate host defense is characterized by a fine balance beor an increase of its secretion. A study by Sugahara and tween an effective inflammatory response and the maintecoworkers (31) showed an increase of SP-A protein and nance of tissue integrity. Monocytes/macrophages are the main cells responsible for maintaining this equilibrium. In mRNA production by type II cells from Day 3 to Day 7 after an intratracheal administration of LPS to rodents. This fact, these cells release a variety of proinflammatory molecules, including TNF-␣, as well as anti-inflammatory mediaincrease in SP-A levels was associated with the proliferation of alveolar epithelial cells. Under our experimental conditors such as IL-10. Reciprocal interactions between these two cytokines control the inflammatory response. Thus, tions, we could not exclude the possibility that the modulation of the SP-A concentration was due to the presence of TNF-␣ plays a role in the induction of IL-10 production by stimulated monocytes (26) , and IL-10 inhibits TNF-␣ PMN. Indeed, PMN secrete numerous serine proteinases (32, 33) and reactive oxygen free radicals (34) that degrade formation (10). Accordingly, the study of IL-10 production is essential to the understanding of the regulation of the SP-A. To test this hypothesis, we removed PMN with the mAb RB6-8C5, and measured SP-A concentrations in LPSinflammatory process.
We previously demonstrated that the administration of challenged mice. We did not find a significant difference between RB6-8C5-treated and control mice (data not LPS in the airways of mice triggers the production of IL-10 inefficiently, but induces the recruitment of inflammatory shown), thus ruling out a possible role of PMN in the modification of SP-A level in BALF. cells, including PMN and mononuclear phagocytes, which are competent to synthesize IL-10 in vitro upon LPS chalWe further showed that the in vivo administration of exogenous SP-A inhibits IL-10 production, and we hypothelenge (15) . Here, we show that a second in vivo administration of LPS which mimics the persistence of an inflammatory sized that this effect was due to an interaction of SP-A with newly recruited monocytes. Indeed, it is known that SP-A stimulus, between Days 1 and 3, triggers in vivo IL-10 production by the newly recruited inflammatory cells. PMN binds to monocytes (35) and that this binding is greater than that observed with in vitro differentiated alveolar macare not thought to produce IL-10 (27), although Romani and coworkers (28) have reported that these cells are able rophages (36) . Monocytes migrate to the lung and enter the alveoli, where they come into contact with surfactant ficient clearance of inhaled pathogens through multiple and differentiate into alveolar macrophages (37) . This difpathways of the innate host defense. ferentiation pathway consists of changes in the cell surface although it has been postulated that surfactant proteins may and ICAM-1 (CD54) (42) . These data provide compelling administration has no effect on TNF-␣ level measured in 1991. IL-10 inhibits cytokine production by activated macrophages. J. geted mice produced significantly more TNF-␣ than wild-
BALF. This is surprising, because it has been demonstrated
